Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma. | PLoS One | 2023 | 37733705 | PubTator, text mining | PubMed |
| A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer. | J Ovarian Res | 2023 | 37730669 | PubTator, text mining | PubMed |
| YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration. | BMC Cancer | 2023 | 37726690 | PubTator, text mining | PubMed |
| CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs. | J Exp Clin Cancer Res | 2023 | 37723588 | PubTator, text mining | PubMed |
| Machine learning developed a programmed cell death signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma. | Transl Oncol | 2023 | 37722290 | PubTator, text mining | PubMed |
| The landscape of implantation and placentation: deciphering the function of dynamic RNA methylation at the maternal-fetal interface. | Front Endocrinol (Lausanne) | 2023 | 37720526 | PubTator, text mining | PubMed |
| IGF2BP3 Enhances the Growth of Hepatocellular Carcinoma Tumors by Regulating the Properties of Macrophages and CD8+ T Cells in the Tumor Microenvironment. | J Clin Transl Hepatol | 2023 | 37719968 | PubTator, text mining | PubMed |
| Dysregulation of core neurodevelopmental pathways-a common feature of cancers with perineural invasion. | Front Genet | 2023 | 37719704 | PubTator, text mining | PubMed |
| Regulation of m6A modification on ferroptosis and its potential significance in radiosensitization. | Cell Death Discov | 2023 | 37714846 | PubTator, text mining | PubMed |
| Ppm1d truncating mutations promote the development of genotoxic stress-induced AML. | Leukemia | 2023 | 37709843 | PubTator, text mining | PubMed |
| KIAA1429/VIRMA promotes breast cancer progression by m6 A-dependent cytosolic HAS2 stabilization. | EMBO Rep | 2023 | 37705505 | PubTator, text mining | PubMed |
| The current landscape of m6A modification in urological cancers. | PeerJ | 2023 | 37701836 | PubTator, text mining | PubMed |
| Development and verification of a newly established cuproptosis-associated lncRNA model for predicting overall survival in uterine corpus endometrial carcinoma. | Transl Cancer Res | 2023 | 37701111 | PubTator, text mining | PubMed |
| Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer. | Transl Cancer Res | 2023 | 37701104 | PubTator, text mining | PubMed |
| N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker. | Cancer Biol Ther | 2023 | 37700507 | PubTator, text mining | PubMed |
| RNA binding protein TIAR modulates HBV replication by tipping the balance of pgRNA translation. | Signal Transduct Target Ther | 2023 | 37699883 | PubTator, text mining | PubMed |
| Dysregulation and implications of N6-methyladenosine modification in renal cell carcinoma. | Curr Urol | 2023 | 37692138 | PubTator, text mining | PubMed |
| Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks. | Int J Mol Sci | 2023 | 37686426 | PubTator, text mining | PubMed |
| CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. | Mol Cancer | 2023 | 37684641 | PubTator, text mining | PubMed |
| Effects of Gestational Arsenic Exposures on Placental and Fetal Development in Mice: The Role of Cyr61 m6A. | Environ Health Perspect | 2023 | 37682722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=29